Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection

Neuropsychopharmacology. 2024 Apr;49(5):770-771. doi: 10.1038/s41386-024-01815-4. Epub 2024 Feb 15.

Authors

Mark A Frye¹, Charles B Nemeroff²

Affiliations

¹ Department of Psychiatry & Psychology, Mayo Clinic, Mayo Clinic Alix School of Medicine, Rochester, MN, USA. MFrye@mayo.edu.
² Department of Psychiatry & Behavioral Sciences, University of Texas at Austin Dell Medical School, Austin, TX, USA.

No abstract available

Publication types

Letter

MeSH terms

Antidepressive Agents / pharmacology
Antidepressive Agents / therapeutic use
Pharmacogenetics*
Pharmacogenomic Testing*

Substances

Antidepressive Agents